Harrison R F, Biswas S
Int J Gynaecol Obstet. 1980 Mar-Apr;17(5):471-6. doi: 10.1002/j.1879-3479.1980.tb00191.x.
Human placental lactogen (HPL), alpha-fetoprotein, prolactin and growth hormones were assayed simultaneously twice weekly in 21 women from 4--16 weeks' gestation. Mean levels were established from 15 of the women for comparison with one woman with a twin pregnancy, two who aborted and three who received progestogen supplements. There was wide interpatient variation in all hormone levels excepting HPL. The mean levels of all except growth hormone showed an upward trend. Mean growth hormone levels were higher initially but remained within a 2--4 ng/ml range throughout. In the twin pregnancy, only HPL and alpha-fetoprotein levels were significantly raised. HPL was detected in one of the two women who aborted, whereas growth hormone was initially extremely high, falling precipitously prior to abortion in both women. Treatment with progestogen supplements did not appear to influence any of the hormones measured. This study suggests that serial estimations of HPL appear to be the most cost-effective guide to early fetal well-being of the four hormones measured.
对21名妊娠4至16周的女性,每周两次同时测定人胎盘催乳素(HPL)、甲胎蛋白、催乳素和生长激素。从其中15名女性身上确定了平均水平,以便与1名怀有双胞胎的女性、2名流产女性和3名接受孕激素补充剂的女性进行比较。除HPL外,所有激素水平在患者之间均存在很大差异。除生长激素外,所有激素的平均水平均呈上升趋势。生长激素的平均水平最初较高,但始终保持在2至4纳克/毫升的范围内。在双胞胎妊娠中,只有HPL和甲胎蛋白水平显著升高。在两名流产女性中的一名检测到了HPL,而生长激素最初极高,在两名女性流产前均急剧下降。补充孕激素似乎并未影响所测的任何激素。这项研究表明,在所测的四种激素中,连续测定HPL似乎是评估早期胎儿健康状况最具成本效益的指标。